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ABSTRACT 
Many environmental and dietary influences can cause immune cells to produce biological 
mediators that increase airway inflammation. A high-fat meal (HFM) is one stimulus that 
increases airway inflammation in healthy individuals. Supplementation with omega-3 fatty acids 
can reduce inflammation systemically and may be beneficial to the airways. Purpose: To 
determine if omega-3 fatty acid supplementation via fish oil would mitigate the airway 
inflammatory response induced by a single HFM. Methods: Seventeen non-asthmatic men (22 ± 
2 yrs.) were supplemented with 3000 mg×day-1 fish oil or a placebo for 3 wks. Fractional 
exhaled nitric oxide (FENO; a marker of airway inflammation), impulse oscillometry (a measure 
of respiratory impedance), pulmonary function, and triglycerides were measured prior to and two 
hours following a HFM. Results: Following a HFM, triglycerides increased in both fish oil and 
placebo groups compared to pre-HFM (~59% and ~49% respectively, p<0.05). The percent 
increase in FENO was greater in the placebo group compared to the fish oil group (25.7 ± 16.7% 
vs. -1.99 ± 10.5% respectively, p<0.05). A significant correlation was observed between blood 
triglycerides and FENO in the placebo group (r=0.61; p<0.05), but not the fish oil group 
(p=0.21).Conclusion: A single HFM increases airway inflammation and omega-3 fatty acid 
supplementation via fish oil protects against HFM associated changes in airway health. 
 
  
INTRODUCTION 
 
Systemic and localized inflammation is triggered by physical injury, microorganisms, chemical 
toxins, and hypersensitivity (Sherwood 2001). These biological responses are associated with 
increased production and release of inflammatory mediators from the blood plasma, white blood 
cells, mast cells, and endothelium all of which contribute to a cascade of additional inflammatory 
processes (Sherwood 2001). In addition, long-term exposure to inflammation is linked with an 
increased risk of several disorders, including atherosclerosis, reheumatoid arthritis, inflammatory 
bowel syndrome, asthma, and adult respiratory distress syndrome (Calder 2003; Libby et al. 
2002). 
 
One recently discovered and often overlooked inflammatory trigger is the nutritional content of 
our diet. Van Oostrom et al. (2003) was one of the first to demonstrate that a single high-fat meal 
(HFM) containing 40% weight/volume fat emulsion increased monocyte and neutrophil count, 
suggesting onset of an inflammatory response. This type of single meal was also used to reveal 
an association between high blood triglycerides and glucose levels and the production of pro-
inflammatory cytokines and oxidative stress (Eriksson et al. 2001; van Oostrom et al. 2003). In 
addition, the recent findings of Rosenkranz et al. (2010) in our laboratory demonstrated for the 
first time that a HFM significantly increased both blood triglycerides and airway inflammation in 
healthy men and women. Thus it becomes evident that some component of dietary fat intake 
elicits an inflammatory response that can be observed both systemically and within the 
pulmonary system.  
 Emergent evidence suggests that omega-6 fatty acids are a primary mechanism mediating the 
inflammatory response observed with high fat diets (Galland 2010). Furthermore, regular intake 
of a pro-inflammatory diet, primarily one including omega-6 fatty acids, is often associated with 
increases in the prevalence of pulmonary distress. The typical western diet often contains 
disproportionately high omega-6 content relative to the omega-3 fatty acids (Simopoulos 2002; 
Simopoulos 2008). As such, individuals from populations traditionally with this type of diet have 
a high percentage of the omega-6 fatty acid arachidonic acid and very low fractions of the 
omega-3 fatty acid eicosapentaenoic acid (EPA) within their inflammatory cells (Gibney and 
Hunter 1993; Sperling et al. 1993). However, dietary supplementation with omega-3 fatty acids 
increases the fraction of omega-3s EPA and docosahezaenoic acid (DHA) within the plasma 
membrane of cells (De Caterina et al. 1994; Kew et al. 2004; Meydani et al. 1993; 
Mickleborough et al. 2006; Mickleborough et al. 2003; Sperling et al. 1993) which subsequently 
produces less biologically active inflammatory mediators (Calder 2003; Obata et al. 1999). 
 
The omega-3 fatty acids EPA and DHA can be derived from a variety of sources including 
marine or fish oil (Whelan and Rust 2006). As such significant associations between fish intake 
and lung function suggest that omega-3 fatty acids may have a beneficial influence on pulmonary 
physiology (Laerum et al. 2007; Schwartz and Weiss 1994). Mickleborough and colleagues have 
demonstrated the protective effects of fish oil on exercise induced bronchoconstriction in 
asthmatic populations (Mickleborough et al. 2006; Mickleborough et al. 2003). In addition, 
Tecklenburg-Lund et al. (2010) reduced airway inflammation in asthmatic subjects following a 
3wk period of fish oil supplementation (Tecklenburg-Lund et al. 2010). However, to date, it is 
unknown if fish oil supplementation for a similar 3 wk period will mitigate the airway 
inflammatory response elicited by a single HFM.  
 
The rationale for the present study was that because omega-3 fatty acids, and by extension fish 
oil, has a systemic anti-inflammatory action, airway inflammation following a HFM would be 
reduced. It was hypothesized that (i) a single HFM would increase post-prandial airway 
inflammation, (ii) a linear relationship would exists between blood triglycerides and airway 
inflammation, and (iii) that 3 wks fish oil supplementation would prevent the HFM post-prandial 
increase in airway inflammation.  
 
MATERIALS AND METHODS 
 
Subjects 
 
Seventeen men (age 22 ± 2 yrs (mean ± SD)) completed the experiments. All subjects had no 
history of cardiovascular, pulmonary, or metabolic disease and were non-smokers as determined 
from medial history questionnaire. Of the subjects none were regularly using anti-oxidant 
supplements or anti-inflammatory drugs. Subjects were excluded if using bronchial dilators, lipid 
lowering medication, or fish oil supplements. Subject’s dietary habits were not directly 
monitored prior to or during the study period, but were continuously instructed to not change 
their diet or physical activity habits. Verbal and written consent was obtained from all subjects. 
The study was approved by the Institutional Review Board for Research Involving Human 
Subjects at Kansas State University, and conformed to the Decleration of Helsenki. 
 
Experimental Design 
 
This study was conducted as a randomized, single blinded trial. Following pre-trial testing (i.e., 
baseline), each subject was randomly assigned to three weeks of either a fish oil supplementation 
condition or a placebo condition. Subjects in the placebo condition continued their normal diet 
plus three similar appearing capsules containing room air. In the fish oil condition; subjects 
continued their normal diet plus three capsules per day containing 1000 mg of fish oil each 
(containing 180 mg EPA and 120 mg DHA; Spring Valley Omega-3 Fish Oil, Springfield MO). 
The reported EPA and DHA contents by the manufacture were not verified prior to the study but 
have been previously reported elsewhere (Harris 2004; Juturu 2008). Subjects were instructed to 
take the pills each day of the experimental period and were asked not to eat fish during the 
course of the study and were contacted regularly to inquire about any adverse reactions and to 
monitor compliance. Subjects visited the laboratory after an overnight fast (12 h) and abstaining 
from exercise (24 h) following the 3 wk supplementation period (Pre-HFM) and 2 h following 
the consumption of a HFM (Post-HFM). At each session, resting measurements of pulmonary 
function, airway impedance, fractional exhaled nitric oxide, and blood triglycerides were made.   
 
The “over-the-counter” HFM used in the present study was identical to that previously employed 
by Rosenkranz et al. (2010). The meal consisted of a fat dose equivalent to 1 g fat per kg 
bodyweight and was composed of ice cream (Edy’s Grand Vanilla) and whipping cream (Reddi 
wip original). Ice cream serving size was measured as ml of ice cream = bodyweight in kg × 
4.0625. Whipping cream was measured as ml of whipped cream = bodyweight in kg × 1.5. The 
nutritional makeup of the HFM was 4.5 g saturated fat (39.8-56.9 g) per serving, 30 mg 
cholesterol (339.7-485.5 mg) per serving, and 16 g of carbohydrate (106.7-152.5 g) per serving. 
The meal was ingested within 20 min. 
 
Experimental Measurements 
 
Pulmonary function was assessed via standard measurements of peak expiratory flow (PEF), 
forced expiratory flow in 1-sec (FEV1), forced expiratory flow at 25-75% of vital capacity 
(FEF25-75), and forced vital capacity (FVC) (SensorMedics 229 Metabolic Cart, SensorMedics 
Corp, Yorba Linda, CA, USA) according to the manufactures guidelines and the American 
Thoracic Society criteria of pulmonary function testing. As such, the highest values from the 
three repeated trials were recorded. Airway impedance was measured using a commercially 
available airway oscillometry system (IOS, Jaeger, Germany) (Vink Pediat Pulmon 2003) 
according to the manufactures guidelines. This system measures impedance (Z) of the total 
respiratory system, from which calculations of resistance (R) and reactance (X) can be made. In 
the present study Z, R, and X were measured across a frequency range of 5-35 Hz. The averages 
of three repeated trials were recorded. Airway inflammation was evaluated using measurements 
of fractional exhaled nitric oxide (FENO) via chemiluminescence (Sievers Nitric Oxide Analyzer 
280, Sievers Instruments Inc, Boulder, CO, USA) in accordance to the manufactures guidelines 
and the American Thoracic Society recommendations. FENO provides reproducible and non-
invasive assessment of inflammation in the lower-respiratory tract (Gabbay et al. 1998). Briefly, 
while wearing a nose piece to prevent contributions of nasal NO, subjects were asked to inhale 
orally to total lung capacity and then immediately perform a constant and controlled exhalation 
flow rate to vital capacity into a rapid NO analyzer. The averages of three repeated trials, all 
within 5% of the mean value, were recorded. A minimum of 30 seconds of relaxed breathing was 
given between trials. Measurements of total cholesterol and triglycerides were determined from a 
finger-stick blood sample and analyzed via an automated lipid analyzer (Cholestech, LDX). 
Measurements of respiratory impedance and blood lipids were not completed in 4 subjects due to 
equipment unavailability (2, fish oil; 2, placebo). Subjects were in a seated position for all 
experimental measurements. 
 
Statistical Analysis 
 
Data are given as mean ± SD except when otherwise stated.  The impact of fish oil 
supplementation (or placebo) and a HFM post-prandial response were tested by two-way 
repeated measures ANOVA with a Newman-Keuls test as a post hoc analysis test. Linear 
correlation analysis was used to assess the relationship between blood triglycerides and airway 
inflammation across individuals in the placebo and fish oil groups. Significance was set at p < 
0.05 for all analyses. 
 
RESULTS 
 
Baseline Characteristics 
 
General subject characteristics and pulmonary function measurements at baseline are shown in 
Table 1. Stature and body mass were not significantly different between fish oil and placebo 
conditions. At baseline standard pulmonary function measurements, FENO, respiratory 
impedance, and blood lipids were not significantly different between experimental groups. 
However, baseline FENO varied by approximately 30 ppb across subjects and may reflect the 
varied caloric and nutritional dietary habits in college aged men.  
 
Standard pulmonary function and Impedance 
 
Following a HFM, triglycerides significantly increased in both fish oil and placebo groups 
compared to pre-HFM (59% and 49% respectively). Standard pulmonary function test and 
respiratory impedance test values pre and post-HFM are shown in Table 2. Pre-HFM values of 
PEF, FEF25-75, and FEV1 were not different between experimental groups. In addition, these 
variables were unchanged (p>0.05) post-HFM compared to pre in both groups. Similar to 
standard pulmonary function variables, measurements of respiratory impedance were similar 
between experimental groups pre-HFM and were unchanged post-HFM.   
 
Exhaled nitric oxide 
 
Figure 1 illustrates the individual and group mean change in FENO before and after HFM. In the 
placebo group, post-HFM FENO significantly increased in 9 of 9 subjects by approximately 4 ppb 
(range: 0.6-11.2) compared to pre-HFM. In the fish oil group, post-HFM FENO did not 
appreciably change compared to pre-HFM (p>0.05). In this group, 2 of 8 subjects demonstrated a 
less than 1.0 ppb elevation in FENO compared to pre-HFM. The percent change in FENO from pre-
HFM was significantly less in the fish oil group compared to the placebo group (-1.99 ± 3.97% 
versus 25.7 ± 35.93% respectively). Figure 2 illustrates the significant association between blood 
triglycerides and FENO in the placebo group pre and post-HFM (r=0.61, p<0.05).  However, the 
regression relating triglycerides and FENO for the fish oil group was not significant (r=0.39, 
p=0.21). 
 
DISCUSSION 
 
The primary findings of the present study are that omega-3 fatty acid supplementation has a post-
prandial anti-inflammatory effect within the pulmonary system and that a significant relationship 
exists between blood triglycerides and airway inflammation. These findings are consistent with 
our first and second hypotheses that a single HFM increases airway inflammation and that its 
increase is associated with triglyceride levels. The third hypothesis was also well supported by 
the data. Three weeks of moderate omega-3 fatty acid supplementation via fish oil mitigated the 
airway inflammatory response following an “over-the-counter” HFM. Taken together these 
observations increase our understanding of the relationship between dietary fat intake and 
provide new insight into the anti-inflammatory effects of fish oil within the pulmonary system.  
 
The findings of the present study extend those reported in previous investigations in our 
laboratory. Using FENO as a biological marker of airway inflammation, Rosenkranz et al. (2010) 
determined that a single HFM increases airway inflammation in non-asthmatic subjects. The 
present study both confirms these findings and extends them by demonstrating a significant 
linear relationship between blood triglycerides and FENO. In addition, the present study 
demonstrates that this relationship is abolished when subjects are supplemented with dietary fish 
oil. These findings advocate that fish oil supplementation has positive implications in healthy 
individuals under dietary induced airway inflammation.  
 
Many food substances induce inflammatory responses following consumption. High fat intake 
(particularly omega-6 fatty acids) is one such substance that can cause and inflammatory reaction 
and since the typical Western diet contains an omega-6/omega-3 ratio greater than 15/1 many 
individuals may be exposed to a pro-inflammatory diet (Simopoulos 2008; Simopoulos 2002). 
van Oostrom et al. (2004) has recently demonstrated that a single meal consisting of fresh cream 
elicits a mild inflammatory response (van Oostrom et al. 2004). Likewise, increases in 
triglycerides and glucose have been shown to be paralleled by the increased production of pro-
inflammatory cytokines and oxidative stress (Eriksson et al. 2001; van Oostrom et al. 2003).  
 
In adults and children, high margarine intake, a substance containing high amounts of omega-6 
fatty acids, has been associated with an increased likelihood of pulmonary distress (Foliaki et al. 
2008; Nagel and Linseisen 2005). Similarly, Rosenkranz et al. (2010) and the current study’s 
placebo group demonstrate that a single HFM increases airway inflammation, but does not 
impact lung volumes or airway reactivity. While the mechanism defining the relationship 
between fat intake and airway inflammation is not well defined, one potential mediator may be 
the fatty acid content of inflammatory cells within the pulmonary system. A Western diet 
containing a high omega-6/omega-3 fatty acid ratio increases the percentage of arachidonic acid 
in the membrane of inflammatory cells and is linked to an increased incidence of asthma (Black 
and Sharpe 1997; Simopoulos 2002; Simopoulos 2008). When present in high amounts 
arachidonic acid becomes the primary substrate used in the synthesis of bioactive mediators and 
cytokines (Calder 2001). Therefore, the HFM induced acute inflammatory response reported by 
Rosenkranz et al. (2010), Van Ostroom et al. (2004) and that of the placebo group in the current 
study may be the result of high arachidonic acid content in the pulmonary system. However, 
these conclusions are only speculative as the present study did not measure changes in the fatty 
acid content of systemic inflammatory or pulmonary cells.  
 
 
Blood lipoprotein properties may also contribute to the HFM induced inflammation. Nichols et 
al. (2006) demonstrated that a high saturated fat meal decreases the anti-inflammatory properties 
of high-density lipoproteins (HDL) (Nicholls et al. 2006). Similarly, Patel et al. (2009) acutely 
induced hypertriglyceridaemia causing the formation of triglyceride-enriched HDL, which 
reduced HDL’s anti-inflammatory properties (Patel et al. 2009). In the present study, the 
significant relationship between triglycerides and airway inflammation reveals that blood 
lipoproteins may explain in part the negative impact of high-fat intake on airway health.  
 
Dietary supplementation with omega-3 fatty acids has a positive influence on inflammatory 
membrane composition and function. Two omega-3 fatty acids, EPA and DHA can replace 
arachidonic acid in the plasma membrane of inflammatory cells (Gibney and Hunter 1993; 
Sperling et al. 1993; Endres et al. 1989; Lee et al. 1985; De Caterina et al. 1994; Meydani et al. 
1993; Mickleborough et al. 2006) and competitively inhibit arachidonic acid metabolism (Endres 
et al. 1989; Lee et al. 1985; Obata et al. 1999). Individuals experimentally supplemented with 
fish oil capsules or fed a controlled high-fish diet demonstrate a decreased capacity to produce 
several inflammatory mediators (Caughey et al. 1996; Endres et al. 1989; Gallai et al. 1995; 
Kinsella et al. 1990; Lewis et al. 1990; Meydani et al. 1993; Sadeghi et al. 1999). 
 
Dietary fish intake is associated with increased pulmonary function and decreased risk of asthma 
and asthma-like symptoms (Laerum et al. 2007; Miyamoto et al. 2007; Schwartz and Weiss 
1994). Biltagi et al. (2009) demonstrated that 6 weeks of omega-3 fatty acid supplementation in 
asthmatic children significantly reduced sputum markers of airway inflammation with a 
concomitant improvement in lung function (Biltagi et al. 2009). Likewise, Mickleborough and 
colleagues (2003, 2006) determined that 3 weeks of dietary omega-3 fatty acid supplementation 
decreases the severity of exercise-induced bronchoconstriction (EIB) in both healthy and 
asthmatic athletes (Mickleborough et al. 2006; Mickleborough et al. 2003). Furthermore, lower 
pre- and post-exercise inflammatory markers in the omega-3 supplement group compared to 
placebo diets paralleled the changes in EIB severity. These findings of Biltagi et al (2009) and 
Mickelborough et al. (2003, 2006), in combination with the present study, demonstrate the broad 
effectiveness of omega-3 fatty acid supplementation on airway inflammation in the healthy and 
diseased lung when exposed to inflammatory stress. 
 
 
Limitations 
 
Previous investigations report an association between airway inflammation and airway hyper-
responsiveness in asthmatic patients (Hancox et al. 2007; Porsbjerg et al. 2009; Rasmussen et al. 
2009). However, the current study did not evaluate airway hyper-responsiveness, only 
measurements of resting pulmonary function and airway impedance. Accurate assessment of 
airway hyper-responsiveness would have required the introduction of a spasmogen, such as 
Methacholine, saline, or exercise. In addition, dietary habits were not monitored prior to or 
during the supplementation period. These unmonitored and uncontrolled dietary habits prior to 
the study period may have contributed to the variability in baseline measurements of FENO and 
blood triglycerides reported in Table 1. However, participants were repeatedly instructed 
throughout the study period not to change their diet and were excluded from participation if they 
consumed fish oil within 2 months prior to the study. Similarly, the EPA and DHA contents of 
the fish oil supplementation were not verified prior to the study. Variability of the omega-3 fatty 
acid content may have contributed to the variability in FENO responses in the supplement group. 
The results of this study, therefore, are attributed to the dose of fish oil prescribed and not the 
specific EPA and DHA contents reported by the manufacture.  
 
Blood triglycerides are increased by the consumption of both fats and carbohydrates. Abbasi et 
al. (2000) demonstrated that a 2-week low-fat, high-carbohydrate diet increases plasma 
triglycerides (Abbasi et al. 2000). These data suggest that the HFM used in the current study and 
that of Rosenkranz et al. (2010) may have been the result of a high carbohydrate intake (16 g 
carbohydrate per serving). However, Ahuga et al. (2009) reports that a single low-fat, high-
carbohydrate meal does not significantly alter blood triglyceride levels (Ahuja et al. 2009). This 
data suggests that acute consumption of carbohydrates does not contribute to increased blood 
triglyceride levels and therefore the post-prandial triglyceride levels observed in the current 
study are attributed primarily to the fat content of the HFM.  
 Conclusion and Relevance 
 
In conclusion, the present study demonstrates for the first time that omega-3 fatty acid 
supplementation mitigates the airway inflammatory response induced by a single HFM. The key 
implications of the present study are twofold. First, the current study in parallel with that of 
Rosenkranz et al. (2010) demonstrate that the healthy airway is sensitive to acute dietary fat 
intake. This information provides insight into the pulmonary inflammatory response, which is 
often only studied in clinical populations. Secondly, the results of the current study suggest that 
only short-term supplementation with a moderate (3000 mg/day) dose of capsulated fish oil is 
required to attenuate the HFM induced airway inflammatory response. Conversely, the HFM 
stimulus used in the current study had no influence on resting pulmonary function. These 
findings suggest that individuals chronically exposed to a high-fat diet may be at an increased 
risk for pulmonary inflammation, but that short-term dietary supplementation with fish oil may 
mitigate these responses. Future studies should focus on determining the potential beneficial 
effects of fish oil supplementation on chronic high-fat consumption and pulmonary health.  
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Fig. 1 Absolute changes in fractional exhaled nitric oxide pre- and post-HFM in placebo (a) and 
supplement group (b). Dashed lines represent individual data and filled circles respresent the group 
mean.  Factional exhaled nitric oxide (airway inflammation) increased ~4 ppb in the placebo group 
after HFM vs. ~−1 ppb in the fish oil group. Asterisks significantly different than pre-HFM (p < 
0.05). Data presented as mean ± SE 
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Figure 2 
Fig. 2 Relationship between blood triglycerides and fractional exhaled 
nitric oxide pre and post-HFM (p < 0.05) 
